Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Government Help For Life Sciences Sector Is Welcomed, But Still Not Enough

This article was originally published in The Pink Sheet Daily

Executive Summary

Therapeutic "clusters" are the next big idea, but unlikely to overshadow industry-academia tie-ups.

You may also be interested in...

Pharma and Academia: Finding New Ways to Join Hands for Mutual Benefit

As Big Pharmas seek to hedge their development risk and look for more externally sourced programs, partnerships with academic institutions are one of the many ingredients in the R&D secret sauce. Such deals aren't the academic-industry tie-ups of yore-where Big Pharma sought small money partnerships without giving a lot back to their academic partners. Business development execs view them as yet another way to access critically important innovation.

UK Life Sciences Package Includes "Innovation Pass" To Skirt NICE

LONDON - The UK 's Life Sciences Blueprint is an urgent bid to kick-start a sector that's increasingly important to the nation's future growth - especially in the light of the downturn in financial services

GSK Partners Leftover Assets With Academia

GlaxoSmithKline's Academic Drug Performance Unit isn't focused on what one might expect -trawling academic institutions for promising science and compounds to eventually bring into the fold

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts